GEN1042 DP, PEMBROLIZUMAB
GCT1042-02
Phase 2 small_molecule active
Quick answer
GEN1042 DP, PEMBROLIZUMAB for Metastatic Solid Malignant tumors is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Metastatic Solid Malignant tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active